BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25909886)

  • 1. Tissue-specific targeting of cell fate regulatory genes by E2f factors.
    Julian LM; Liu Y; Pakenham CA; Dugal-Tessier D; Ruzhynsky V; Bae S; Tsai SY; Leone G; Slack RS; Blais A
    Cell Death Differ; 2016 Apr; 23(4):565-75. PubMed ID: 25909886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors.
    Kel AE; Kel-Margoulis OV; Farnham PJ; Bartley SM; Wingender E; Zhang MQ
    J Mol Biol; 2001 May; 309(1):99-120. PubMed ID: 11491305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide identification of potential plant E2F target genes.
    Vandepoele K; Vlieghe K; Florquin K; Hennig L; Beemster GT; Gruissem W; Van de Peer Y; Inzé D; De Veylder L
    Plant Physiol; 2005 Sep; 139(1):316-28. PubMed ID: 16126853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F Transcription Factors Control the Roller Coaster Ride of Cell Cycle Gene Expression.
    Thurlings I; de Bruin A
    Methods Mol Biol; 2016; 1342():71-88. PubMed ID: 26254918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial gene control involving E2F and E Box family members.
    Giangrande PH; Zhu W; Rempel RE; Laakso N; Nevins JR
    EMBO J; 2004 Mar; 23(6):1336-47. PubMed ID: 15014447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity.
    Sun H; Chang Y; Schweers B; Dyer MA; Zhang X; Hayward SW; Goodrich DW
    Mol Cell Biol; 2006 Feb; 26(4):1527-37. PubMed ID: 16449662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A; Iaquinta PJ; Verona R; Lees JA
    Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of E2F1-specific target genes.
    Wells J; Graveel CR; Bartley SM; Madore SJ; Farnham PJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3890-5. PubMed ID: 11904439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
    Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
    Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.
    de Bruin A; Maiti B; Jakoi L; Timmers C; Buerki R; Leone G
    J Biol Chem; 2003 Oct; 278(43):42041-9. PubMed ID: 12893818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation.
    Asp P; Acosta-Alvear D; Tsikitis M; van Oevelen C; Dynlacht BD
    Genes Dev; 2009 Jan; 23(1):37-53. PubMed ID: 19136625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the Arf/p53 tumor surveillance network by E2F.
    Iaquinta PJ; Aslanian A; Lees JA
    Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
    Kim TA; Ravitz MJ; Wenner CE
    J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBL2-E2F-GCN5 guide cell fate decisions during tissue specification by regulating cell-cycle-dependent fluctuations of non-cell-autonomous signaling.
    Militi S; Nibhani R; Jalali M; Pauklin S
    Cell Rep; 2023 Sep; 42(9):113146. PubMed ID: 37725511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
    Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
    Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins.
    Gartel AL; Goufman E; Tevosian SG; Shih H; Yee AS; Tyner AL
    Oncogene; 1998 Dec; 17(26):3463-9. PubMed ID: 10030670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.